| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/29/2013 | CN103120795A Preparation targeting macrophages |
| 05/29/2013 | CN103120778A External medicinal liquor |
| 05/29/2013 | CN103120739A Medicinal liquor with blood circulation accelerating health-care function and preparation method thereof |
| 05/29/2013 | CN103120730A Medicament for treating dysentery |
| 05/29/2013 | CN103120721A Chinese medicinal composition for treating wind-heat common cold and preparation method and application thereof |
| 05/29/2013 | CN103120676A Application of Eryngiolide A in medicine for treating rheumatoid arthritis |
| 05/29/2013 | CN103120671A Application of Aphanamixoid A in medicine for treating rheumatoid arthritis |
| 05/29/2013 | CN103120669A Application of Eryngiolide A in medicine for treating rhinitis |
| 05/29/2013 | CN103120658A Application of Eryngiolide A in medicine for resisting aseptic inflammation |
| 05/29/2013 | CN103120655A Composition for amelioration/prevention of adverse side effect in steroid therapy |
| 05/29/2013 | CN103120642A Gel used for skin diseases and preparation method thereof |
| 05/29/2013 | CN102772342B Traditional Chinese medicine toothpaste capable of diminishing inflammation and relieving pain |
| 05/29/2013 | CN102626392B Solid preparation of doxycycline ambroxol medicine compound |
| 05/29/2013 | CN102626381B Vesicular phospholipid gel injection of latamoxef sodium |
| 05/29/2013 | CN102614182B Solid preparation of compound ammonia phenol renin medicine composition liposome |
| 05/29/2013 | CN102558393B Preparation process of dalteparin sodium |
| 05/29/2013 | CN102526082B Compound glycyrrhizin soluble powder for livestock and preparation method thereof |
| 05/29/2013 | CN102406595B Floating microorganism adhesive porous hydrogel and preparation method thereof |
| 05/29/2013 | CN102250188B Ursolic acid series medicament with anti-inflammatory and anti-tumor activity and preparation thereof |
| 05/29/2013 | CN102204968B External defervescence liquid medicine for treating infant anemopyretic cold |
| 05/29/2013 | CN102188674B Health-care liquid for promoting blood circulation, removing blood stasis and freeing bi |
| 05/29/2013 | CN101889953B Device and method for manufacturing drug smoke liquid and drug smoke |
| 05/29/2013 | CN101861301B Dioxoanthracene sulphonate derivatives |
| 05/29/2013 | CN101538218B Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 05/29/2013 | CN101506145B Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 05/29/2013 | CN101434593B Two crystal substances of baicalin, and preparations, pharmaceutical composition and uses thereof |
| 05/29/2013 | CN101429185B Two-crystal type of substance of meletin, production method, medicament composition and uses thereof |
| 05/29/2013 | CN101322734B Codonopsis lanceolata total saponins with anti-inflammatory immunity function and preparation thereof |
| 05/29/2013 | CN101235041B Four kinds of tripterygium wilfordii derivative and preparing method of pharmaceutics thereof |
| 05/29/2013 | CN101028325B Medicinal composition containing sailonggu, and its preparation and quality detection method |
| 05/28/2013 | US8450329 Benzoxazole kinase inhibitors and methods of use |
| 05/28/2013 | US8450319 Pyrrolopyridazinone compound |
| 05/28/2013 | US8450309 Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation |
| 05/28/2013 | US8450306 Bradykinin B1-receptor antagonists |
| 05/28/2013 | CA2739883C Cyclohexane derivative and pharmaceutical use thereof |
| 05/28/2013 | CA2714295C Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/28/2013 | CA2685447C Pharmaceutical composition |
| 05/28/2013 | CA2603371C Trihydroxy polyunsaturated eicosanoid derivatives |
| 05/28/2013 | CA2588338C Compositions comprising azelastine and methods of use thereof |
| 05/28/2013 | CA2547887C Protein modifier production inhibitor |
| 05/28/2013 | CA2530385C Melt extruded controlled release oxycodone multiparticulates |
| 05/28/2013 | CA2485346C Human adam-10 inhibitors |
| 05/28/2013 | CA2476935C Drug delivery system for subconjunctival administration of fine particles |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2473970C Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 05/28/2013 | CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/28/2013 | CA2453301C Synthetic double-stranded oligonucleotides for specific inhibition of gene expression |
| 05/28/2013 | CA2440831C Combination therapy using cd40 and cd20 ligands |
| 05/28/2013 | CA2423876C Novel selective bradykinin (bk) b1 peptidic receptor antagonists and uses thereof |
| 05/23/2013 | WO2013074738A1 Compositions and methods for treating autoimmune and inflammatory disorders |
| 05/23/2013 | WO2013074320A1 Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain |
| 05/23/2013 | WO2013073648A1 Anti-inflammatory functional agent for oral application |
| 05/23/2013 | WO2013073577A1 Dihydroxy aromatic heterocyclic compound |
| 05/23/2013 | WO2013072896A1 Structural variants of mycolactones for use in modulating inflammation, immunity and pain |
| 05/23/2013 | WO2013072825A1 Phtalazinone derivatives as mpegs -1 inhibitors |
| 05/23/2013 | WO2013072390A2 Stilbene compounds as ppar beta/delta inhibitors for treating ppar beta/delta transmitted illnesses |
| 05/23/2013 | WO2013048214A3 Novel heterocyclic derivatives and their uses |
| 05/23/2013 | WO2013030669A3 Compositions comprising thymoquinone for the treatment of inflammatory diseases |
| 05/23/2013 | US20130131804 Joint Repair Using Mesenchymal Stem Cells |
| 05/23/2013 | US20130131038 N-containing heteroaryl derivatives as jak3 kinase inhibitors |
| 05/23/2013 | US20130131026 Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant |
| 05/23/2013 | US20130129808 Medical product containing active component of propolis or grapefruit seed extract and manufacturing method thereof |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | CA2854809A1 Compositions and methods for treating autoimmune and inflammatory disorders |
| 05/22/2013 | EP2594561A1 Structural variants of mycolactones for use in modulating inflammation, immunity and pain |
| 05/22/2013 | EP2594555A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 05/22/2013 | EP2594280A1 Activin neutralisers and uses thereof for treatment of diseases associated with aberrant "host defence response" activation |
| 05/22/2013 | EP2593457A1 Pyrazolo [1, 5a]pyrimidine and thieno [3, 2b]pyrimidine derivatives as irak4 modulators |
| 05/22/2013 | EP2593432A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
| 05/22/2013 | EP2593427A1 Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain |
| 05/22/2013 | EP2593141A2 Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
| 05/22/2013 | EP2593098A2 Methods and compositions for cancer immunotherapy |
| 05/22/2013 | EP2593095A1 (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| 05/22/2013 | CN103119045A Pyrrolopyrimidine compounds and uses thereof |
| 05/22/2013 | CN103119043A Fused heterocyclic compound and application thereof |
| 05/22/2013 | CN103119039A Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 05/22/2013 | CN103119038A 4 - (5 - isoxazolyl or 5 - pyrrazolyl -1,2,4- oxadiazol - 3 - yl) -mandelic acid amides as sphingosin- 1 - phosphate 1 rreceptor agonists |
| 05/22/2013 | CN103119031A 取代酰胺化合物 Substituted amide compounds |
| 05/22/2013 | CN103119030A Matrix metalloproteinase inhibitors |
| 05/22/2013 | CN103119028A 1,2,4-Triazolone Derivative |
| 05/22/2013 | CN103119025A Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them |
| 05/22/2013 | CN103119021A Anti-inflammatory agents |
| 05/22/2013 | CN103118696A Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl tRNA synthetases |
| 05/22/2013 | CN103118693A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases |
| 05/22/2013 | CN103118692A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase |
| 05/22/2013 | CN103118678A Methods and compositions for cancer immunotherapy |
| 05/22/2013 | CN103113483A Method for extracting various active ingredients from dendrobium officinale |
| 05/22/2013 | CN103113466A Recombinant human interferon beta-1b modified by polyethylene glycol and preparation method of recombinant human interferon beta-1b |
| 05/22/2013 | CN103113432A Iridoids, and preparation method and application thereof |
| 05/22/2013 | CN103113419A Multi-response supramolecular hydrogel factor, hydrogel and preparation method thereof |
| 05/22/2013 | CN103113382A Group of sesquiterpenoid coumarin and sesquiterpenoid chromone compounds |
| 05/22/2013 | CN103113375A Pyrazolo [3, 4-d] pyrimidine compounds and preparation method thereof |
| 05/22/2013 | CN103113359A Silibinin diunsymsuccinate and pharmaceutical salt thereof |
| 05/22/2013 | CN103113353A Triazole compounds, medical composition thereof and preparation and application of triazole compounds |
| 05/22/2013 | CN103113342A Benzo-seven-member heterocyclic compounds as well as preparation method and application thereof |
| 05/22/2013 | CN103113307A 苯并咪唑类化合物及其应用 Benzimidazole compounds and their Applications |
| 05/22/2013 | CN103113303A Nitrogen heterocyclic compound used as CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells) receptor antagonist |
| 05/22/2013 | CN103113274A Ras and HDAC dual inhibitor as well as preparation method and application thereof |
| 05/22/2013 | CN103113216A Naproxen sodium crystal compound, medical composition and preparation method thereof |
| 05/22/2013 | CN103113196A Glechoma longituba phenol, and preparation method and application thereof |